Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma
利妥昔单抗、大剂量甲氨蝶呤联合奥拉替尼作为新诊断的原发性中枢神经系统淋巴瘤的诱导治疗
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02658-8
Zhao, Shi-Hua; Zhu, Zun-Min; Yang, Tao; Gao, Da; Liu, Li-Hong; Yang, Wei; Wang, Xiao-Bo; Zhao, Yu-Xia; Li, Meng; Gao, Yi-Nan; Ma, Rong-Jun; Yang, Ying; Li, Hui-Ping; Li, Li; Ao, Xiao-Lei; Xiao, Xiu-Bin; Hu, Chong-Ling; Yuan, Shun-Zong; Ding, Yao; Chen, Xi-Lin; He, Jian-Xia; Liu, Yao; Huang, Wen-Rong
